ISTH Diagnosis of Thrombotic Thrombocytopenic Purpura Guideline Summary - Guideline Central
Diagnosis
Treatment
Document Overview

Diagnosis of Thrombotic Thrombocytopenic Purpura

International Society on Thrombosis and Haemostasis


Publication Date: Jun 17, 2025

Page Last Updated: May 5, 2026


GRADE Strength of Recommendations and Implications


Document Overview

Document Title
Diagnosis of Thrombotic Thrombocytopenic Purpura
Authoring Society

International Society on Thrombosis and Haemostasis

Document Publication Date
Jun 17, 2025
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
onlinelibrary.wiley.com/doi/10.1111/jth.15006
Source Citation

Zheng XL, Al-Housni Z, Cataland SR, Coppo P, Geldziler B, Germini F, Iorio A, Keepanasseri A, Masias C, Matsumoto M, McCrae KR, McIntyre J, Mustafa RA, Peyvandi F, Russell L, Tarawneh R, Vesely SK; International Society on Thrombosis and Haemostasis. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2025 Jun 17:S1538-7836(25)00360-5. doi: 10.1016/j.jtha.2025.06.002. Epub ahead of print. PMID: 40533296.


Document Scope, Criteria, and Use Cases

Document Objectives

The evidence-based guidelines of the International Society on Thrombosisand Haemostasis (ISTH) are intended to support patients, clinicians, and other healthcare professionals in their decisions about the initial diagnosis and management ofacute Thrombotic thrombocytopenic purpura (TTP).

Scope
Diagnosis, Management
Diseases/Conditions (MeSH)

D003933 - Diagnosis

D011697 - Purpura, Thrombotic Thrombocytopenic

D003933 - Diagnosis

D011697 - Purpura, Thrombotic Thrombocytopenic

Keywords
ADAMTS13, Guidelines, TTP, diagnosis, thrombosis
Target Patient Population
adult patients with a suspected Thrombotic thrombocytopenic purpura (TTP)
Target Provider Population
Primary care physicians, emergency orcritical care physicians, hematologists, nephrologists, neurologists, pathologists or transfusion medicine specialists, surgeons, obstetricians and gynecologists, as well as hospitalists
Inclusion Criteria
Male, Female, Adult
Health Care Settings
Ambulatory, Hospital, Long Term Care
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Data Supplement
Number of Source Documents
133
Includes peer/external review process?
Yes
Includes public comment process?
Yes
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
No
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.